Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 155.20
-2.55 (-1.62%)
At close: Jan 21, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 207.81 billion as of January 23, 2026. Its market cap has decreased by -38.49% in one year.
Market Cap
207.81B
Enterprise Value
248.88B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
155.20
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 207.81B, a decrease of -8.35%. That is a compound annual growth rate of -2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 207.81B | -9.12% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 384.52B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.52B |
| Caplin Point Laboratories | 135.05B |
| Granules India | 134.12B |
| Rubicon Research | 109.37B |
| Sanofi India | 93.47B |